Managing malignant disease in patients with porphyria

16Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Certain types of porphyria have an increased incidence of malignant disease. In addition, patients with all forms of porphyria may develop malignant disease as a 'normal life event'. The investigation and treatment of porphyric patients with malignant disease requires specific precautions to minimize the risk of an acute porphyric attack, and to ensure optimum treatment of the malignancy. We briefly review the biochemical basis, clinical features and current management of porphyria in cancer patients. © Association of Physicians 2004; all rights reserved.

Cite

CITATION STYLE

APA

Palmieri, C., Vigushin, D. M., & Peters, T. J. (2004). Managing malignant disease in patients with porphyria. QJM: An International Journal of Medicine. Oxford University Press. https://doi.org/10.1093/qjmed/hch027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free